Analysts have been eager to weigh in on the Healthcare sector with new ratings on Biogen (BIIB), Neurocrine (NBIX) and Beyondspring (BYSI).
Biogen (BIIB)
In a report issued on March 16, Matt Phipps from William Blair reiterated a Hold rating on Biogen. The company’s shares closed last Friday at $267.07.
According to TipRanks.com, Phipps is a 3-star analyst with an average return of 3.6% and a 44.5% success rate. Phipps covers the Healthcare sector, focusing on stocks such as Phasebio Pharmaceuticals, Pieris Pharmaceuticals, and Autolus Therapeutics.
Biogen has an analyst consensus of Moderate Buy, with a price target consensus of $307.42.
See today’s analyst top recommended stocks >>
Neurocrine (NBIX)
In a report issued on March 16, Myles Minter from William Blair maintained a Buy rating on Neurocrine. The company’s shares closed last Friday at $92.22.
According to TipRanks.com, Minter is a 4-star analyst with an average return of 18.6% and a 54.9% success rate. Minter covers the Healthcare sector, focusing on stocks such as Minerva Neurosciences, Silence Therapeutics, and Larimar Therapeutics.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Neurocrine with a $123.30 average price target, which is a 36.1% upside from current levels. In a report issued on March 2, Raymond James also maintained a Buy rating on the stock.
Beyondspring (BYSI)
William Blair analyst Andy Hsieh reiterated a Buy rating on Beyondspring yesterday. The company’s shares closed last Friday at $12.44.
According to TipRanks.com, Hsieh is a 4-star analyst with an average return of 19.6% and a 58.5% success rate. Hsieh covers the Healthcare sector, focusing on stocks such as Actinium Pharmaceuticals, Nektar Therapeutics, and Viking Therapeutics.
Currently, the analyst consensus on Beyondspring is a Strong Buy with an average price target of $27.50.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
